Table 3.

Correlations of expression levels of DLX1 and miR‐539 with clinicopathological features of the patients with prostate cancer

Clinicopathological features	DLX1 expression		P	miR‐539 expression		P
	Low	High		Low	High
Age (year)			0.138			0.274
<60	21	15		16	20
≥60	43	55		54	44
Family history			0.706			0.508
No	29	34		31	32
Yes	35	36		39	32
Lymph node metastasis			0.023			0.003
No	40	30		28	42
Yes	24	40		42	22
Pathological stages			0.036			0.004
High differentiation	29	17		17	29
Moderate differentiation	13	18		14	17
Low differentiation	22	35		39	18e
Tumour size			0.012			0.033
<2 cm	48	38		39	47
≥2 cm	16	32		31e	17
Gleason scores			0.001			0.030
<7	51	37		40	48
≥7	13	33		30	16

Abbreviations: DLX1, distal‐less homeobox 1; miR‐539, microRNA‐539.